GTM vs JAZZ · P/E 6.9, rev $620.6M vs P/E 1988, rev $2.28B
ZoomInfo Technologies Inc. (GTM) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
ZoomInfo Technologies Inc. (GTM) is a software - application company listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported GTM revenue for 2026-06-30 was $620.6M. Net income was -$614.4M. GTM currently screens at market cap $816.4M and trailing P/E 6.9.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
GTM currently screens at market cap $816.4M and trailing P/E 6.9. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the GTM and JAZZ stock pages for the full models.
Not investment advice.